Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01781429
Title Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors BioMed Valley Discoveries, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Med-Hematology & Oncology Los Angeles California 90095 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Florida Cancer Specialists and Research Group (Sarah Cannon Research Institute) Sarasota Florida 34232 United States Details
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Institute Hospital at Vanderbilt Nashville Tennessee 37203 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37212 United States Details
UT M.D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field